YOU ARE HERE: (Aidsmap)
Gilead is negotiating voluntary licenses with `seven or eight` Indian manufacturers to make the anti-HIV drug tenofovir within the next year, after obtaining a patent on tenofovir in India. The company hopes that by granting voluntary licenses it will be able to increase production capacity.

FDA to Clarify Conflict Rules for U.S. Drug Approvals (Update1) (Bloomberg.com)
July 24 (Bloomberg) -- The U.S. Food and Drug Administration plans to write new guidelines specifying when outside scientists and doctors serving on agency advisory panels should be disqualified because of conflicts of interest.